Publication

Differentiating among stages of cognitive impairment in aging: Version 3 of the Uniform Data Set (UDS) neuropsychological test battery and MoCA index scores.

Downloadable Content

Persistent URL
Last modified
  • 05/15/2025
Type of Material
Authors
    Hiroko H. Dodge, Layton Aging and Alzheimer's Disease Center Oregon Health & Science UniversityFelicia Goldstein, Emory UniversityNicole I. Wakim, Department of Biostatistics University of MichiganTamar Gefen, The Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Department of Psychiatry and Behavioral Sciences, Feinberg School of Medicine, Northwestern UniversityMerilee Teylan, National Alzheimer's Coordinating Center University of WashingtonKwun C.G. Chan, National Alzheimer's Coordinating Center University of WashingtonWalter A. Kukull, National Alzheimer's Coordinating Center University of WashingtonLisa L. Barnes, Rush Alzheimer's Disease Center Rush University Medical CenterBruno Giordani, Michigan Alzheimer's Disease Center University of MichiganTimothy M. Hughes, The Wake Forest Alzheimer's Disease Research Center, Wake Forest School of MedicineJoel H. Kramer, Memory and Aging Center University of California San FranciscoDavid A. Loewenstein, Center for Cognitive Neuroscience and Aging University of Miami Miller School of MedicineDaniel C. Marson, Alzheimer's Disease Center University of Alabama at BirminghamDan M. Mungas, The UC Davis Alzheimer's Disease Research CenterNora Mattek, Layton Aging and Alzheimer's Disease Center Oregon Health & Science UniversityBonnie C. Sachs, The Wake Forest Alzheimer's Disease Research Center, Wake Forest School of MedicineDavid P. Salmon, The Shiley-Marcos Alzheimer's Disease Research Center University of California, San DiegoMonica Parker, Emory UniversityKathleen A. Welsh-Bohmer, Alzheimer's Disease Research Center Duke UniversityKatherine V. Wild, Layton Aging and Alzheimer's Disease Center Oregon Health & Science UniversityJohn C. Morris, Knight Alzheimer Disease Research Center Washington University School of MedicineSandra Weintraub, The Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Department of Psychiatry and Behavioral Sciences, Feinberg School of Medicine, Northwestern University
Language
  • English
Date
  • 2020
Publisher
  • Wiley Periodicals, Inc.
Publication Version
Copyright Statement
  • © 2020 The Authors.
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 6
Issue
  • 1
Start Page
  • e12103
End Page
  • e12103
Grant/Funding Information
  • The NACC database is funded by NIA/NIH Grant U01 AG016976. NACC data are contributed by the NIA‐funded ADCs: P30 AG019610 (PI Eric Reiman, MD), P30 AG013846 (PI Neil Kowall, MD), P50 AG008702 (PI Scott Small, MD), P50 AG025688 (PI Allan Levey, MD, PhD), P50 AG047266 (PI Todd Golde, MD, PhD), P30 AG010133 (PI Andrew Saykin, PsyD), P50 AG005146 (PI Marilyn Albert, PhD), P50 AG005134 (PI Bradley Hyman, MD, PhD), P50 AG016574 (PI Ronald Petersen, MD, PhD), P50 AG005138 (PI Mary Sano, PhD), P30 AG008051 (PI Thomas Wisniewski, MD), P30 AG013854 (PI M. Marsel Mesulam, MD), P30 AG008017 (PI Jeffrey Kaye, MD), P30 AG010161 (PI David Bennett, MD), P50 AG047366 (PI Victor Henderson, MD, MS), P30 AG010129 (PI Charles DeCarli, MD), P50 AG016573 (PI Frank LaFerla, PhD), P50 AG005131 (PI James Brewer, MD, PhD), P50 AG023501 (PI Bruce Miller, MD), P30 AG035982 (PI Russell Swerdlow, MD), P30 AG028383 (PI Linda Van Eldik, PhD), P30 AG053760 (PI Henry Paulson, MD, PhD), P30 AG010124 (PI John Trojanowski, MD, PhD), P50 AG005133 (PI Oscar Lopez, MD), P50 AG005142 (PI Helena Chui, MD), P30 AG012300 (PI Roger Rosenberg, MD), P30 AG049638 (PI Suzanne Craft, PhD), P50 AG005136 (PI Thomas Grabowski, MD), P50 AG033514 (PI Sanjay Asthana, MD, FRCP), P50 AG005681 (PI John Morris, MD), P50 AG047270 (PI Stephen Strittmatter, MD, PhD), and P30 AG053760 (PI Henry Paulson, MD).
Supplemental Material (URL)
Abstract
  • INTRODUCTION: Federally funded Alzheimer's Disease Centers in the United States have been using a standardized neuropsychological test battery as part of the National Alzheimer's Coordinating Center Uniform Data Set (UDS) since 2005. Version 3 (V3) of the UDS replaced the previous version (V2) in 2015. We compared V2 and V3 neuropsychological tests with respect to their ability to distinguish among the Clinical Dementia Rating (CDR) global scores of 0, 0.5, and 1. METHODS: First, we matched participants receiving V2 tests (V2 cohort) and V3 tests (V3 cohort) in their cognitive functions using tests common to both versions. Then, we compared receiver-operating characteristic (ROC) area under the curve in differentiating CDRs for the remaining tests. RESULTS: Some V3 tests performed better than V2 tests in differentiating between CDR 0.5 and 0, but the improvement was limited to Caucasian participants. DISCUSSION: Further efforts to improve the ability for early identification of cognitive decline among diverse racial groups are required.
Author Notes
  • Hiroko H. Dodge, Department of Neurology, Oregon Health & Science University, CR 131, 3181 SW Sam Jackson Park Road, Portland, OR 97239.
Keywords
Research Categories
  • Health Sciences, Public Health
  • Biology, Neuroscience

Tools

Relations

In Collection:

Items